GREENLAND MINES LTD Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GREENLAND MINES LTD stock issued during period, value, other for the quarter ending 2025-06-30 was $500.00K.
- GREENLAND MINES LTD stock issued during period, value, other for the quarter ending 2025-03-31 was $679.58K.
- GREENLAND MINES LTD stock issued during period, value, other for the quarter ending 2022-06-30 was -$462.54K.
- GREENLAND MINES LTD stock issued during period, value, other for fiscal 2022 was -$462.54K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-18 | |
| 2025-03-31 | $679.58K 10-Q · filed 2025-05-15 | |
| 2022-12-31 | -$462.54K 10-K · filed 2024-04-17 | |
| 2022-06-30 | -$462.54K 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |